Chronic Disease RDT Portfolio

About SD BioSensor

SD Biosensor is a publicly traded diagnostics powerhouse that leverages its core biosensor and lateral flow assay technologies to develop, manufacture, and commercialize a wide range of diagnostic products. The company achieved significant global scale and recognition through its COVID-19 test kits, supplied worldwide via partnerships with major organizations like Roche and the Bill & Melinda Gates Foundation. Its strategic focus now includes diversifying its infectious disease portfolio, expanding into chronic disease diagnostics, and enhancing its automated diagnostic platforms to drive long-term growth beyond the pandemic.

Therapeutic Areas